Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David H Canaday

Showing results (81-90 of 122) with videos related to

Pageof 13
Sort By:
Infection and Immunity|May 16, 2002
Identification by mass spectrometry of CD8(+)-T-cell Mycobacterium tuberculosis epitopes within the Rv0341 gene productDavid C Flyer, Venkatesh Ramakrishna, Cara Miller, et al.
The Journal of Clinical Investigation|December 3, 2013
Sprouty-2 regulates HIV-specific T cell polyfunctionalityYen-Ling Chiu, Liang Shan, Hailiang Huang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 31, 2014
Circulating CXCR5+PD-1+ response predicts influenza vaccine antibody responses in young adults but not elderly adultsRamin Sedaghat Herati, Morgan A Reuter, Douglas V Dolfi, et al.
Pathogens & Immunity|March 3, 2023
Differential CD4+ T-Cell Cytokine and Cytotoxic Responses Between Reactivation and Latent Phases of Herpes Zoster InfectionWenjie Jin, Mike Fang, Ismail Sayin, et al.
Medrxiv : the Preprint Server for Health Sciences|March 18, 2024
Ongoing evolution of SARS-CoV-2 drives escape from mRNA vaccine-induced humoral immunityAlex L Roederer, Yi Cao, Kerri St Denis, et al.
Cell Reports. Medicine|December 10, 2024
Ongoing evolution of SARS-CoV-2 drives escape from mRNA vaccine-induced humoral immunityAlex L Roederer, Yi Cao, Kerri St Denis, et al.
JCI Insight|April 20, 2017
T-bet+ B cells are induced by human viral infections and dominate the HIV gp140 responseJames J Knox, Marcus Buggert, Lela Kardava, et al.
NPJ Vaccines|January 26, 2018
A heterogeneous human immunodeficiency virus-like particle (VLP) formulation produced by a novel vector systemJoshua Pankrac, Katja Klein, Paul F McKay, et al.
Medrxiv : the Preprint Server for Health Sciences|May 10, 2023
Durability of immunity and clinical protection in nursing home residents following bivalent SARS-CoV-2 vaccinationStefan Gravenstein, Frank DeVone, Oladayo A Oyebanji, et al.
Plos One|April 9, 2021
Immune cells in bronchoalveolar lavage fluid of Ugandan adults who resist versus those who develop latent Mycobacterium tuberculosis infectionBonnie A Thiel, William Worodria, Sophie Nalukwago, et al.
Pageof 13

Showing results (81-90 of 122) with videos related to

Sort By:
Pageof 13
Infection and Immunity|May 16, 2002
Identification by mass spectrometry of CD8(+)-T-cell Mycobacterium tuberculosis epitopes within the Rv0341 gene productDavid C Flyer, Venkatesh Ramakrishna, Cara Miller, et al.
The Journal of Clinical Investigation|December 3, 2013
Sprouty-2 regulates HIV-specific T cell polyfunctionalityYen-Ling Chiu, Liang Shan, Hailiang Huang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 31, 2014
Circulating CXCR5+PD-1+ response predicts influenza vaccine antibody responses in young adults but not elderly adultsRamin Sedaghat Herati, Morgan A Reuter, Douglas V Dolfi, et al.
Pathogens & Immunity|March 3, 2023
Differential CD4+ T-Cell Cytokine and Cytotoxic Responses Between Reactivation and Latent Phases of Herpes Zoster InfectionWenjie Jin, Mike Fang, Ismail Sayin, et al.
Medrxiv : the Preprint Server for Health Sciences|March 18, 2024
Ongoing evolution of SARS-CoV-2 drives escape from mRNA vaccine-induced humoral immunityAlex L Roederer, Yi Cao, Kerri St Denis, et al.
Cell Reports. Medicine|December 10, 2024
Ongoing evolution of SARS-CoV-2 drives escape from mRNA vaccine-induced humoral immunityAlex L Roederer, Yi Cao, Kerri St Denis, et al.
JCI Insight|April 20, 2017
T-bet+ B cells are induced by human viral infections and dominate the HIV gp140 responseJames J Knox, Marcus Buggert, Lela Kardava, et al.
NPJ Vaccines|January 26, 2018
A heterogeneous human immunodeficiency virus-like particle (VLP) formulation produced by a novel vector systemJoshua Pankrac, Katja Klein, Paul F McKay, et al.
Medrxiv : the Preprint Server for Health Sciences|May 10, 2023
Durability of immunity and clinical protection in nursing home residents following bivalent SARS-CoV-2 vaccinationStefan Gravenstein, Frank DeVone, Oladayo A Oyebanji, et al.
Plos One|April 9, 2021
Immune cells in bronchoalveolar lavage fluid of Ugandan adults who resist versus those who develop latent Mycobacterium tuberculosis infectionBonnie A Thiel, William Worodria, Sophie Nalukwago, et al.
Pageof 13